Johnson Matthey (LON:JMAT – Get Free Report)‘s stock had its “restricted” rating reaffirmed by equities research analysts at Jefferies Financial Group in a research note issued to investors on Friday,London Stock Exchange reports.
JMAT has been the topic of several other research reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the company a “buy” rating in a research note on Tuesday, April 7th. Berenberg Bank lowered their price target on shares of Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating on the stock in a report on Monday, March 23rd. Finally, UBS Group reaffirmed a “neutral” rating and issued a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday, May 22nd. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,218.33.
View Our Latest Report on JMAT
Johnson Matthey Stock Down 1.2%
Johnson Matthey (LON:JMAT – Get Free Report) last posted its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share (EPS) for the quarter. The business had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative net margin of 1.13% and a negative return on equity of 5.87%. Equities analysts anticipate that Johnson Matthey will post 173.4112903 EPS for the current fiscal year.
Insider Buying and Selling at Johnson Matthey
In related news, insider Alastair Judge purchased 14 shares of Johnson Matthey stock in a transaction on Wednesday, April 15th. The stock was bought at an average price of GBX 2,022 per share, with a total value of £283.08. Also, insider Liam Condon purchased 14 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were bought at an average price of GBX 1,941 per share, with a total value of £271.74. Insiders have acquired 72 shares of company stock worth $146,198 over the last three months. Company insiders own 0.51% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
- Marvell’s Pullback May Be the Setup Bulls Were Waiting For
- Flight Path to Profits: American Airlines Bets on SpaceX
- Wall Street Is Starting to Talk About Tesla’s Endgame
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
